|
PSMB10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.960100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.297880E-02 |
| Normal-vs-Stage2 |
7.238000E-01 |
| Normal-vs-Stage3 |
9.649700E-02 |
| Normal-vs-Stage4 |
3.008600E-01 |
| Stage1-vs-Stage2 |
6.834600E-04 |
| Stage1-vs-Stage3 |
4.813200E-01 |
| Stage1-vs-Stage4 |
1.387240E-01 |
| Stage2-vs-Stage3 |
1.658420E-02 |
| Stage2-vs-Stage4 |
9.551900E-02 |
| Stage3-vs-Stage4 |
4.852800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.920300E-02 |
| Normal-vs-AfricanAmerican |
9.864200E-01 |
| Normal-vs-Asian |
3.748500E-02 |
| Caucasian-vs-AfricanAmerican |
3.080000E-02 |
| Caucasian-vs-Asian |
5.547000E-01 |
| AfricanAmerican-vs-Asian |
5.484200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.116440E-01 |
| Normal-vs-Female |
4.887800E-02 |
| Male-vs-Female |
7.377000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.001980E-02 |
| Normal-vs-Age(41-60Yrs) |
7.350100E-02 |
| Normal-vs-Age(61-80Yrs) |
6.934400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.683200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.593850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.941600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.109600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.080200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.307000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.662000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.536000E-01 |
| Classical-VS-Follicular |
2.77950000004967E-06 |
| Classical-VS-Other |
6.505800E-01 |
| Classical-VS-Normal |
8.410200E-02 |
| Tall-VS-Follicular |
1.445980E-02 |
| Tall-VS-Other |
4.961200E-01 |
| Tall-VS-Normal |
8.506000E-02 |
| Follicular-VS-Other |
3.009000E-01 |
| Follicular-VS-Normal |
4.597000E-01 |
| Other-VS-Normal |
7.328200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.551800E-02 |
| Normal-vs-N1 |
8.089600E-02 |
| N0-vs-N1 |
8.183200E-01 |
|
|
